ICU · cardiovascular
Acute decompensated heart failure — comprehensive ICU management (ADHF, cardiogenic shock overlap)
Also known as ADHF · Acute heart failure · Cardiogenic pulmonary oedema · Flash pulmonary oedema · Acute decompensated heart failure · Cardiogenic shock · Warm and wet · Cold and wet · Stevenson classification · Nohria profiles · DOSE trial · CARRESS-HF · 3CPO trial · ADHERE registry · ADVOR trial
Acute decompensated heart failure (ADHF): an admission for worsening heart failure producing congestion and/or hypoperfusion. CLASSIFICATION (Nohria/Stevenson bedside profiles): congestion (WET vs DRY) x perfusion (WARM vs COLD); in the 452-patient cohort wet-warm n=222, wet-cold n=91, dry-warm n=123, dry-cold n=16, and the congested profiles predicted death or urgent transplant. PRECIPITANTS (OPTIMIZE-HF): pneumonia/respiratory process, ischaemia, arrhythmia, uncontrolled hypertension, non-adherence and worsening renal function. MANAGEMENT: oxygen only if hypoxaemic, early NIV for respiratory distress (3CPO: faster dyspnoea and metabolic improvement, no 7-day mortality difference), IV loop diuretic (DOSE) with early response assessment (HFA), IV vasodilators when SBP over 110 mmHg (ESC 2021; Cotter high-dose nitrate), noradrenaline over dopamine in cardiogenic shock (SOAP II), selective short-term MCS (IABP-SHOCK II, ECLS-SHOCK, DanGer Shock), ultrafiltration not first-line (CARRESS-HF), avoid routine morphine (ADHERE), continue beta-blockers where possible (meta-analysis) and up-titrate GDMT rapidly after discharge (STRONG-HF).
Checked against its sources on 8 Oct 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Classify first: the Nohria/Stevenson profile (warm/cold x wet/dry) — congested profiles B and C carried a multivariate HR 2.48 for death or urgent transplant.
- Cold and wet with low SBP and hypoperfusion = cardiogenic shock: noradrenaline over dopamine (SOAP II: more arrhythmia and more cardiogenic-shock deaths with dopamine) plus an inotrope, with specialist MCS decisions.
- NIV as soon as possible for respiratory distress (RR over 25, SpO2 under 90%) — 3CPO: faster dyspnoea and metabolic improvement, no short-term mortality difference.
- Assess diuretic response early: spot urine sodium under 50-70 mEq/L at 2 h and/or urine output under 100-150 mL/h in the first 6 h signals an insufficient response (HFA).
- IV vasodilators only when SBP is over 110 mmHg; never in the hypotensive, hypoperfused patient.
- Ultrafiltration is NOT first-line — CARRESS-HF: worse creatinine, similar weight loss, more serious adverse events.
- Avoid routine morphine (ADHERE analysis: more ventilation, ICU admission and mortality) and routine inotropes in the non-hypoperfused patient (OPTIME-CHF, PROMISE).
- Venous congestion, not low output, is the haemodynamic factor most associated with worsening renal function (Mullens) — keep decongesting while the patient is still congested.
- Continue beta-blockers if the clinical picture allows (withdrawal associated with higher in-hospital mortality) and up-titrate GDMT rapidly after discharge (STRONG-HF).
Meet the patient
A 72-year-old man with known HFrEF (LVEF 28 per cent) sits bolt upright on the ward, grey, sweating, respiratory rate 36, SpO2 86 per cent on a simple mask. He ran out of his bisoprolol and sacubitril-valsartan a week ago. Bedside: SBP 168, warm peripheries, JVP to the ear, bibasal crackles — a warm-wet profile, the commonest group in the Nohria cohort. Respiratory rate over 25 and SpO2 under 90 per cent: NIV goes on now.[3][24]
The question that decides the next drug is the one that decides every ADHF admission: is this patient wet or dry, and warm or cold? Hold that 2x2 and every infusion below slots into place.[3]
References24ShowHide
- [1]Adams K F Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J, 2005.PMID 15846257
- [2]Fonarow GC, Adams K F Jr, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA, 2005.PMID 15687312
- [3]Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure J Am Coll Cardiol, 2003.PMID 12767667
- [4]Gray A, Goodacre S, Newby DE, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema N Engl J Med, 2008.PMID 18614781
- [5]Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure N Engl J Med, 2011.PMID 21366472
- [6]Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, 2019.PMID 30600580
- [7]Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome N Engl J Med, 2012.PMID 23131078
- [8]De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med, 2010.PMID 20200382
- [9]Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock N Engl J Med, 2012.PMID 22920912
- [10]Peacock WF, Hollander JE, Diercks DB, et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis Emerg Med J, 2008.PMID 18356349
- [11]Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema Lancet, 1998.PMID 9482291
- [12]Long B, Brady WJ, Gottlieb M, et al. Emergency medicine updates: Sympathetic crashing acute pulmonary edema Am J Emerg Med, 2025.PMID 39799613
- [13]Cuffe MS, Califf RM, Adams K F Jr, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA, 2002.PMID 11911756
- [14]Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group N Engl J Med, 1991.PMID 1944425
- [15]Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol, 2009.PMID 19215833
- [16]Shahverdi E, Shahverdi A, Schneider C, et al. Optimization and Real-World Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: A Contemporary Clinical Review Cardiol Res, 2026.PMID 42016211
- [17]Guidi JL, Allen BR, Headden G, et al. A novel NT-proBNP assay for heart failure diagnosis: A prospective, multicenter clinical trial Clin Chim Acta, 2025.PMID 40107595
- [18]Mullens W, Dauw J, Martens P, et al. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload N Engl J Med, 2022.PMID 36027559
- [19]Fonarow GC, Abraham WT, Albert NM, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Archives of internal medicine, 2008.PMID 18443260
- [20]Prins KW, Neill JM, Tyler JO, et al. Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis. JACC. Heart failure, 2015.PMID 26251094
- [21]Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet (London, England), 2022.PMID 36356631
- [22]Thiele H, Zeymer U, Akin I, et al. Extracorporeal Life Support in Infarct-Related Cardiogenic Shock. The New England journal of medicine, 2023.PMID 37634145
- [23]Møller JE, Engstrøm T, Jensen LO, et al. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. The New England journal of medicine, 2024.PMID 38587239
- [24]McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal, 2021.PMID 34447992